Intersect ENT Reports Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Intersect ENT (XENT) Misses Q2 EPS by 9c, Revenues Beat
August 4, 2020 7:23 AM EDTIntersect ENT (NASDAQ: XENT) reported Q2 EPS of ($0.65), $0.09 worse than the analyst estimate of ($0.56). Revenue for the quarter came in at $9.8 million versus the consensus estimate of $5.41 million.
Second Quarter 2020 Overview
Revenue of $9.8 million in the second quarter of 2020, compared to $26.7 million in the second quarter of 2019Strong sales trend reinforces confidence in sequential second half revenue growthCash, Cash Equivalents and Short-term Investments of $135.8 million"While well below last year, we achieved... More



